BackPacific Biosciences of California Overview
Pacific Biosciences of California Inc

Pacific Biosciences of California Target Price

See how PACB's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.3

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-14Barclays$123.1% downsideOpen
2025-08-08BernsteinEve Burstein$1.730.8% upsideOpen
2025-06-25BarclaysLuke Sergott$1.515.4% upsideOpen
2024-06-03JefferiesTycho Peterson$4207.7% upsideOpen
2024-05-13Morgan StanleyTejas Savant$4207.7% upsideOpen
2024-05-13Piper SandlerDavid Westenberg$253.8% upsideOpen
2024-05-10BarclaysLuke Sergott$253.8% upsideOpen
2024-04-18Goldman SachsMatthew Sykes$2.592.3% upsideOpen
2024-04-16Canaccord GenuityKyle Mikson$3.5169.2% upsideOpen
2022-11-16Canaccord Genuity$14976.9% upsideOpen
2022-08-17Piper SandlerDavid Westenberg$7.5476.9% upsideOpen
2022-05-15Piper SandlerDavid Westenberg$6361.5% upsideOpen
2022-01-12Piper SandlerDavid Westenberg$201438.5% upsideOpen

Pacific Biosciences of California (PACB) FAQ

Stockcircle tracks target price for Pacific Biosciences of California (PACB), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Pacific Biosciences of California's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main PACB overview so you can move from this figure to the surrounding analysis quickly.